Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1981 4
1982 1
1983 2
1984 1
1987 1
1988 4
1989 2
1990 5
1991 5
1992 6
1993 14
1994 19
1995 25
1996 18
1997 21
1998 32
1999 20
2000 34
2001 34
2002 29
2003 42
2004 44
2005 43
2006 56
2007 56
2008 56
2009 55
2010 72
2011 69
2012 78
2013 67
2014 67
2015 70
2016 79
2017 54
2018 57
2019 52
2020 57
2021 70
2022 50
2023 47
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,358 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Abnormality of bone mineral density"
Page 1
Antipsychotic-induced hyperprolactinemia.
Bostwick JR, Guthrie SK, Ellingrod VL. Bostwick JR, et al. Pharmacotherapy. 2009 Jan;29(1):64-73. doi: 10.1592/phco.29.1.64. Pharmacotherapy. 2009. PMID: 19113797 Free article. Review.
Use of antipsychotic agents has been associated with hyperprolactinemia, or elevated prolactin levels; this hormonal abnormality can interfere with the functioning of reproductive, endocrine, and metabolic systems. ...Hyperprolactinemia has short- and long-term consequence …
Use of antipsychotic agents has been associated with hyperprolactinemia, or elevated prolactin levels; this hormonal abnormality can …
Bisphosphonate therapy for osteogenesis imperfecta.
Dwan K, Phillipi CA, Steiner RD, Basel D. Dwan K, et al. Cochrane Database Syst Rev. 2016 Oct 19;10(10):CD005088. doi: 10.1002/14651858.CD005088.pub4. Cochrane Database Syst Rev. 2016. PMID: 27760454 Free PMC article. Review.
OBJECTIVES: To assess the effectiveness and safety of bisphosphonates in increasing bone mineral density, reducing fractures and improving clinical function in people with osteogenesis imperfecta. ...In the remaining trial a statistically signif …
OBJECTIVES: To assess the effectiveness and safety of bisphosphonates in increasing bone mineral density, reducing frac …
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.
Pepe J, Body JJ, Hadji P, McCloskey E, Meier C, Obermayer-Pietsch B, Palermo A, Tsourdi E, Zillikens MC, Langdahl B, Ferrari S. Pepe J, et al. J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa306. doi: 10.1210/clinem/dgaa306. J Clin Endocrinol Metab. 2020. PMID: 32453819 Free article. Review.
RESULTS: Fragility fractures in PW are rare and mostly due to secondary osteoporosis (ie, in presence of an underlying disease such as hormonal, inflammatory, or digestive disorders). In absence of another disorder, low bone mineral density (BMD) together wit …
RESULTS: Fragility fractures in PW are rare and mostly due to secondary osteoporosis (ie, in presence of an underlying disease such as hormo …
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group. Black DM, et al. JAMA. 2006 Dec 27;296(24):2927-38. doi: 10.1001/jama.296.24.2927. JAMA. 2006. PMID: 17190893 Clinical Trial.
OBJECTIVE: To compare the effects of discontinuing alendronate treatment after 5 years vs continuing for 10 years. DESIGN AND SETTING: Randomized, double-blind trial conducted at 10 US clinical centers that participated in the Fracture Intervention Trial …
OBJECTIVE: To compare the effects of discontinuing alendronate treatment after 5 years vs continuing for 10 years. DESIGN AND SETTING: Ra …
Swyer syndrome.
King TF, Conway GS. King TF, et al. Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):504-10. doi: 10.1097/MED.0000000000000113. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 25314337 Review.
RECENT FINDINGS: Recent discoveries have broadened our understanding of the complex pathways involved in normal and abnormal sex development. In 46,XY gonadal dysgenesis, lack of testis development may be triggered by sex determining region Y, NR5A1, DHH or testis-determin …
RECENT FINDINGS: Recent discoveries have broadened our understanding of the complex pathways involved in normal and abnormal sex deve …
Metabolic Effects of Oxytocin.
McCormack SE, Blevins JE, Lawson EA. McCormack SE, et al. Endocr Rev. 2020 Apr 1;41(2):121-45. doi: 10.1210/endrev/bnz012. Endocr Rev. 2020. PMID: 31803919 Free PMC article. Review.
In some human observational studies, circulating OXT concentrations are also positively associated with lean mass and bone mineral density. The impact of exogenous OXT on human obesity is the focus of ongoing investigation. Future randomized, placebo-c …
In some human observational studies, circulating OXT concentrations are also positively associated with lean mass and bone mineral …
Bone imaging in hypoparathyroidism.
Silva BC, Rubin MR, Cusano NE, Bilezikian JP. Silva BC, et al. Osteoporos Int. 2017 Feb;28(2):463-471. doi: 10.1007/s00198-016-3750-0. Epub 2016 Aug 30. Osteoporos Int. 2017. PMID: 27577725 Review.
Trabecular bone score (TBS), an indirect measure of bone microarchitecture, also appears to be normal in HypoPT. ...It is not clear whether these structural and the dynamic skeletal abnormalities in HypoPT affect bone strength or fracture risk. Treatme …
Trabecular bone score (TBS), an indirect measure of bone microarchitecture, also appears to be normal in HypoPT. ...It is not …
Endocrinology of bone mineralization: An update.
Jannin A, Kerlan V, Desailloud R. Jannin A, et al. Ann Endocrinol (Paris). 2022 Feb;83(1):46-53. doi: 10.1016/j.ando.2021.12.001. Epub 2021 Dec 16. Ann Endocrinol (Paris). 2022. PMID: 34921812 Review.
Osteomalacia is a rare disorder, corresponding to mineralization abnormalities in adult bone, as opposed to rickets in children. Renal phosphate loss and hypophosphatasia are the main causes of vitamin-resistant osteomalacia. ...The question of treatment sequencing …
Osteomalacia is a rare disorder, corresponding to mineralization abnormalities in adult bone, as opposed to rickets in childre …
Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
Bover J, Bailone L, López-Báez V, Benito S, Ciceri P, Galassi A, Cozzolino M. Bover J, et al. J Nephrol. 2017 Oct;30(5):677-687. doi: 10.1007/s40620-017-0404-z. Epub 2017 Apr 21. J Nephrol. 2017. PMID: 28432640 Review.
Osteoporosis and chronic kidney disease (CKD) have both independently important potential impact on bone health. A significant number of patients with CKD stages 3a-5D have been shown to have low bone mineral density (BMD), leading to a strikingly elev …
Osteoporosis and chronic kidney disease (CKD) have both independently important potential impact on bone health. A significant number …
Mineral and Bone Disease in Kidney Transplant Recipients.
Altman AM, Sprague SM. Altman AM, et al. Curr Osteoporos Rep. 2018 Dec;16(6):703-711. doi: 10.1007/s11914-018-0490-4. Curr Osteoporos Rep. 2018. PMID: 30390201 Review.
While bone mineral density screening appears to help predict fracture risk and anti-osteoporotic therapy appears to have a positive effect on bone mineral density, more data regarding specific treatment is necessary. ...Recent changes in …
While bone mineral density screening appears to help predict fracture risk and anti-osteoporotic therapy appears to hav …
1,358 results